Robinhood Stock Surged Another 60% Sparking More Attention On Retail Trading Trends
Penny stocks are a frequent focus of retail traders. And it looks like Robinhood IPO (NASDAQ: HOOD) has brought a bit more fuel to the fire. The latest public offering sparked controversy, mainly among the “Ape army,” whose apparent “sworn enemy” become available for trading last week. This latest IPO was one of the more disappointing ones this year. Shares of HOOD stock opened at $38, promptly reached highs of $40.25, and then slid to lows of $33.25 the following day. That’s where the sad story ends, and the turnaround story begins.
Love it or hate it, the app has opened doors for millions of new traders over the last few years. If you look at some of the brokerage growth statistics from 2020, Robinhood was among the fastest-growing platforms for new traders. Now that shares of the platform are publicly traded, investors have an opportunity to own a piece of this growth.
Clearly, the sentiment has gone from negative to positive, and the “revenge trade” has become a major focus of retail traders this week. HOOD stock has now managed a rally of more than 130% since the start of the week. What some of the “Ape community” had hoped for is now the exact opposite and may have even converted some of them into Robinhood supporters (at least in the stock market today).
Top Reddit Stocks To Watch
This year has been a big year for “sympathy” momentum. For those unfamiliar, this is where we see stocks breakout without any apparent catalyst. But another company with similar traits and momentum sparks intrigue to find “the next one.” Whether it’s been meme stocks, short-squeeze stocks, COVID stocks, cannabis stocks, and the like, sympathy sentiment is a driver that isn’t ignored. Today, HOOD stock seems to have made its presence known, and now the hoards of Reddit retail traders are on the hunt for more. In this article, we’ll take a look at a few former penny stocks that’ve now begun climbing after the latest HOOD stock IPO:
- GT Biopharma Inc. (NASDAQ: GTBP)
- Bit Digital Inc. (NASDAQ: BTBT)
- BeyondSpring Inc. (NASDAQ: BYSI)
- Lending Club Corp. (NYSE: LC)
GT Biopharma Inc. (NASDAQ: GTBP)
This week GT Biopharma turned some heads after reporting positive results for one of its cancer treatments. In particular, its GTB-3550 (“B7H3 TriKE”) showed effectiveness in promoting cancer cell killing in various indications. The next step is to file an Investigational New Drug Application with the FDA for evaluation in humans. This wasn’t an anomaly either.
Previous studies combined with other drugs like Fate Therapeutics’ (NASDAQ: FATE) FT538 iNK cells. In published results from November, FT538 iNK cells targeted tumor cells in prostate cancer. Researchers of the study said that “the combination of B7H3 TriKE with an off-the-shelf NK cell therapy presents an appealing therapeutic strategy for the treatment of solid tumors with decreased risk of toxicity in allogeneic settings compared to T-cell derived products.”
When asked for further color on the data earlier this year, GT Biopharma’s CEO, Anthony Cataldo, told PennyStocks.com, “GT Biopharma’s TriKE technology is a clear breakthrough in cancer treatment. Not only has it shown early success in hematologic diseases like acute myeloid leukemia, but the potential also demonstrated in combination with Fate’s FT538 iPSC NK cells opens up endless possibilities for the application of TriKE combination treatment in other potential drug therapy platforms targeting things like IL-15.”
Thanks to more attention on cancer stocks recently, GTBP stock has seen a rebound in the market. Shares have bounced back from lows of $9.74 last week to highs of over $11 this week. Companies like Merck (NYSE: MRK), Novartis (NYSE: NVS), and Bristol-Myers Squibb (NYSE: BMY) have all released new details on their related cancer pipelines that’ve brought new interest in this part of the biotech industry this month. Given that the GT Biopharma pipeline includes candidates with upcoming data expected, it has been on the list of former penny stocks to watch.
Bit Digital Inc. (NASDAQ: BTBT)
A rebound in cryptocurrency, including Bitcoin and Ethereum, has related companies in the spotlight this week. Bit Digital is among the names of former penny stocks to watch. The company was one we first discussed late in July. At the time, Bit Digital’s news of a planned Bitcoin mining expansion with Digihost acted as the initial catalyst. The two will operate a 100 MW Bitcoin mining system for an initial 2-year term.
Since then, a mix of speculation and crypto market momentum has helped carry BTBT stock much higher. In fact, since our July 26th update, shares have climbed from under $5 to over $12 this week. Traders also seem to be recirculating that last update, fixated on comments from CEO Bryan Bullett:
As previously announced, we anticipate significant purchase activity in the coming months, due to spot market dislocation in China and our unique access to that market. This agreement with Digihost secures a key component of activating this opportunity, and is expected to enable rapid deployment of newly purchased miners.
One of the things to keep in mind is that no matter how strong the momentum for Bitcoin stocks, the underlying trend in the cryptocurrency’s price tends to direct the market. We’ve seen big breakouts and quick breakdowns thanks to crypto volatility. So make sure to have that in the back of your head if BTBT stock is on your list right now.
BeyondSpring Inc. (NASDAQ: BYSI)
Another cancer treatment stock to watch this week is BeyondSpring. While the massive momentum seen during Wednesday’s premarket session settled down after the open, BYSI stock remains active. While it isn’t necessarily one of the penny stocks of the past, it has made a similar move that we’ve become very familiar with, especially with cheaper stocks. In this case, BYSI closed August 3rd’s session at $9.63, and by the pre-market session on the 4th, it had reached a high of $46.60.
Why is BYSI stock up today? It has everything to do with the latest news released on Wednesday. The company announced positive topline results from its DUBLIN-3 registrations trial. This was of its plinabulin combined with docetaxel in treating non-small cell lung cancer. The study met primary and key secondary endpoints showing “statistically significant improvements” in survival.
“A pre-NDA meeting will be scheduled with the FDA in 2021 to agree on the contents for our NDA, to support a NSCLC indication NDA submission in the first half of 2022. This will be the second indication and second NDA for plinabulin. The superior benefit of plinabulin in reducing severe neutropenia of docetaxel in DUBLIN -3 further supports our first NDA submission in CIN prevention, which received FDA priority review with a PDUFA date of November 30, 2021.”Dr. Lan Huang , BeyondSpring’s co-founder, CEO and Chairwoman
Now the clock starts ticking. While November may seem far away, it’s only just a few months. Given the early reaction in the stock market today, BYSI stock has found itself on plenty of watch lists heading into the second half of the year.
Lending Club Corp. (NYSE: LC)
Believe it or not, less than a year ago, Lending Club Corp. was considered a penny stock. Shares traded as low as $4.32, and trading volume was much lower in comparison to where it’s at right now. A strong string of earnings reports helped spark the initial rally in the stock. Post pandemic needs for capital have also been a factor.
Last month, LC stock saw one of its biggest 1-day jumps thanks to strong Q2 earnings that sparked a flurry of analyst upgrades. The company beat estimates by a mile, with EPS coming in at 9 cents. Estimates pegged the company reporting a loss per share of $0.43. Sales also beat by a wide margin coming in at over $200 million compared to estimates of just $134.55 million. Revenue guidance for Q3 was also raised. Wedbush, Credit Suisse, and Janney were among analysts raising targets and valuations on the company.
Comments from Scott Sanborn, LendingClub’s CEO, also helped lift sentiment. “This is the beginning of a dramatically enhanced earnings trajectory for the business,” Sanborn said. “Our transformation is fueled by our competitive advantages, which include our 3.5 million-plus members, deep data capabilities, marketplace model, as well as our more efficient operating platform. Our earnings are being bolstered by our bank, which is generating a new stream of recurring net interest income that is only beginning to contribute to our bottom-line results.”
Are Reddit Penny Stocks & Former Penny Stocks On Your List?
Whether HOOD stock or Reddit have played a role in your decision-making, retail sentiment is clearly bullish right now. Not only have small-cap stocks gained a bit more ground this week, so have a wide range of names that’ve become popular on mainstream social media outlets. Trends ranging from cancer treatment to Bitcoin mining are becoming a point of interest, so now may be a time to start putting together a new list of stocks to watch in light of this surge in market action.
Pursuant to an agreement between Midam Ventures LLC and GT Biopharma (GTBP) Midam has been paid $150,000 for a period from March 1, 2021, to April 1, 2021. This compensation is payment 1 of 12 as part of a 12-month agreement between Midam Ventures LLC & GT Biopharma (GTBP), for a period from March 1, 2021, to February 28, 2022. Midam Ventures LLC expects to be paid $150,000 per month for a total of 12 months by GT Biopharma (GTBP). Midam has been paid an additional $150,000 for a period from April 2, 2021, to May 1, 2021. This compensation is payment 2 of 12 as part of the Agreement. Midam has been paid an additional $150,000 for a period from May 2, 2021, to June 1, 2021. This compensation is payment 3 of 12 as part of the Agreement. Midam has been paid an additional $150,000 for a period from June 2, 2021, to July 1, 2021. This compensation is payment 4 of 12 as part of the Agreement. Midam has been paid an additional $200,000 for a period from July 2, 2021, to July 29, 2021. This compensation is payment 5 of 12 as part of the Agreement. Midam has been paid an additional $200,000 for a period from July 29, 2021, to September 2, 2021. This compensation is payment 6 of 12 as part of the Agreement. We may buy or sell additional shares of GT Biopharma (GTBP) in the open market at any time, including before, during, or after the Website and Information, to provide public dissemination of favorable Information about GT Biopharma (GTBP). Click here for full disclaimer.nasdaq stocks pandemic cryptocurrency bitcoin ethereum crypto small-cap penny stocks crypto
Largest Uranium-producing Countries
Which country had the highest uranium production in the world in 2020? Kazakhstan topped the list, followed by Australia and Namibia.
The post Largest Uranium-producing Countries appeared first on Investing News Network.
Output from the top uranium-producing countries rose steadily for a decade, leading to a peak of 63,207 tonnes in 2016. However, global uranium production has noticeably declined in the past five years.
The lower production numbers are related to the persistently low spot price the uranium market has experienced over the last seven years; COVID-19 has also had an impact on global uranium output. While prices have begun to rebound, there is much work to be done for the industry to reach the strength seen prior to the 2011 Fukushima disaster.
The majority of mined uranium makes its way into the nuclear energy sector. Currently, 10 percent of the world’s electricity is generated by nuclear energy, and that number is expected to grow. Another by-product of mined ore is uranium oxide, which is used in glass, ceramics and for optic applications.
10 largest uranium-producing countries
Due to its significance in energy generation, it’s important to know where uranium is mined and which nations are the largest uranium-producing countries.
Kazakhstan is the leader by a long shot, and has been since 2009. Last year, it was followed by Australia and Namibia in second and third place, respectively.
For investors interested in following the uranium space, having familiarity with these uranium production hotspots is essential. Read on to get a closer look at 2020’s largest uranium-producing countries. All statistics are from the World Nuclear Association’s most recent report on uranium mine production.
Mine production: 19,477 tonnes
As mentioned, Kazakhstan had the highest uranium production in the world in 2020. In fact, the country’s total output of 19,477 tonnes accounted for 41 percent of global uranium supply.
When last recorded in 2019, Kazakhstan had 906,800 tonnes of known recoverable uranium resources, second only to Australia. Most of the uranium in the country is mined via an in situ leaching process. Kazataprom (LSE:KAP), the country’s national uranium-mining company, is the world’s largest uranium producer with a number of projects and partnerships in various jurisdictions.
Mine production: 6,203 tonnes
Australia’s uranium production decreased slightly in 2020 to 6,203 tonnes, down from 2019’s 6,613 tonnes. The island nation holds 28 percent of the world’s known recoverable uranium resources.
Uranium mining has been a contentious and often political issue in Australia. While the sector is heavily regulated, the future of the industry is often called into question. Recently, the Western Australian government decided to allow existing projects to go ahead, but was clear that no new domestic uranium-mining projects will be approved. This decision has left a number of companies in limbo.
Australia is home to Olympic Dam, the largest-known deposit of uranium in the world. While the country permits some uranium-mining activity, it is opposed to using nuclear energy. A new partnership between Australia, the US and the UK that will allow the Oceanic country to acquire nuclear submarines has renewed debate over whether the country should develop its own nuclear energy capacity.
Mine production: 5,413 tonnes
Namibia’s uranium production has been steadily increasing after falling to a low of 2,993 tonnes in 2015. In fact, the African nation overtook longtime frontrunner Canada to become the third largest uranium-producing country in 2020, putting out 5,413 tonnes of the material.
The country is home to two uranium mines that are capable of producing 10 percent of the world’s output. Uranium miner Paladin Energy (ASX:PDN,OTCQX:PALAF) owns the Langer Heinrich mine, and mining major Rio Tinto (NYSE:RIO,ASX:RIO,LSE:RIO) controls the majority of the Rössing mine.
In 2017, Paladin took Langer Heinrich offline due to weak uranium prices. In 2020, the uranium spot price began to rise, prompting the uranium miner to ramp up restart efforts.
Mine production: 3,885 tonnes
Canada’s uranium output has fallen dramatically in recent years since hitting a peak of 14,039 tonnes in 2016. After producing 6,938 tonnes of yellowcake in 2019, Canadian uranium production sank to 3,885 tonnes in 2020 as the COVID-19 pandemic led to operational shutdowns.
Uranium exploration is also very prevalent in Canada, with the majority occurring in the uranium-dense Athabasca Basin. That particular area of Saskatchewan is world renowned for its high-quality uranium deposits and friendly mining attitude. The province’s long history with the uranium-mining industry has helped Saskatchewan assert itself as an international leader in the uranium sector.
Mine production: 3,500 tonnes
In 2020, with an estimated 3,500 tonnes of output, Uzbekistan became one of the top five uranium-producing countries. Domestic uranium production has been gradually increasing in the Central Asian nation since 2016. Previously the seventh in terms of global uranium output, it is expanding production via Japanese and Chinese joint ventures.
Navoi Mining & Metallurgy Combinat is part of state holding company Kyzylkumredmetzoloto, and handles all the mining and processing of the domestic uranium supply.
Mine production: 2,991 tonnes
Niger’s uranium production has declined year-over-year over the past decade, with output totaling 2,991 tonnes in 2020. The African nation has two uranium mines in production, SOMAIR and COMINAK, which account for 5.5 percent of the world’s uranium production.
Both projects are operated by subsidiaries of Orano, a private uranium miner with projects in top uranium-producing countries Kazakhstan and Canada.
Niger is also home to the flagship project of explorer GoviEx Uranium (TSXV:GXU,OTCQB:GVXXF). The uranium company is presently developing its Madaeouela asset, as well as projects in Zambia and Mali.
Mine production: 2,846 tonnes
Russia was in seventh place in terms of uranium production in 2020. Output has been steady in the country since 2011, usually coming in near the 3,000 tonne range.
The top uranium-producing country is expected to increase its production in the coming years to meet its energy needs and growing uranium demand around the world. However, Russian uranium has been an area of controversy in recent years, with the US conducting a Section 232 investigation around the security of uranium imports from that region.
In terms of domestic uranium production, Rosatom, a subsidiary of ARMZ Uranium Holding, owns the country’s Priargunsky underground mine and is working on developing the Vershinnoye deposit in Southern Siberia through a subsidiary.
Mine production: 1,885 tonnes
China’s uranium production rose from 885 tonnes in 2011 to 1,885 tonnes in 2018, and has been holding steady since then. China General Nuclear Power, the country’s sole domestic uranium supplier, is looking to expand nuclear fuel supply deals with Kazakhstan and additional foreign uranium companies.
China’s goal is to supply one-third of its nuclear fuel cycle with uranium from domestic producers, obtain one-third through foreign equity in mines and joint ventures overseas and purchase one-third on the open uranium market. China is also leading the way in nuclear energy generation; Mainland China has 51 nuclear reactors with an additional 18 in construction.
Mine production: 400 tonnes
After reaching a high of 1,200 tonnes in 2015, uranium production in Ukraine slid to 800 tonnes in 2016. After a few more years at around the 800 tonne level, output dropped to 400 tonnes in 2020.
Ukraine is heavily dependent on nuclear power, and has 15 reactors that meet about half of the country’s electricity requirements. Most of its uranium demand is met through Russian uranium.
Ukraine holds just 2 percent of the world’s known uranium reserves; in comparison, neighboring Russia accounts for 8 percent of the world’s uranium reserves.
Mine production: 400 tonnes
Rounding out the list is India, which produced 400 tonnes of the energy fuel in 2020. The country’s uranium output has held steady between 300 and 420 tonnes over the past decade.
As of 2018, the country had uranium stockpiles of 71,000 tonnes dedicated to its domestic nuclear energy sector. India currently has 23 operating nuclear reactors with another seven under construction. “The Indian government is committed to growing its nuclear power capacity as part of its massive infrastructure development programme,” according to the World Nuclear Association.
“The government has set ambitious targets to grow nuclear capacity.”
Don’t forget to follow us @INN_Resource for real-time news updates!
Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.
Best Dividend Stocks In 2021? 4 To Watch This Week
Dividend stocks to know amidst debates over debt limit and choppy markets.
The post Best Dividend Stocks In 2021? 4 To Watch This Week appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.
4 Dividend Stocks Worth Checking Out In A Down Market
As we begin another trading week, dividend stocks are once again at the forefront for investors. For the most part, this could be thanks to various factors, international and domestic, that are weighing on the stock market today. To begin, the market appears to be reacting to significant declines in overseas equities. The likes of which are closely linked to the possible default of a major Chinese real estate company, Evergrande. If anything, this would echo the aftermath of a recent slew of disappointing international economic data influencing the overall recovery trade now.
At the same time, investors could also be treading lightly ahead of the Federal Reserve’s September meeting. The monetary policy meeting would be the launching point for additional debate regarding the Fed’s tapering and overall economic outlook. Now, how would dividend stocks fit into all of this? Simply put, dividend stocks would be a more defensive play in the stock market now. Given the numerous factors contributing to overall volatility across the board, some consistent income in the form of dividends would be appealing.
Accordingly, companies such as Consolidated Edison (NYSE: ED) and Archer-Daniels-Midland (NYSE: ADM) would come into play. This is mostly because of their long history of dividend growth and a constant demand for their services regardless of the current economic cycle. Among the top dividend stocks now are also industry giants that boast massive operations spanning the globe. With all that said, here are four dividend stocks to note now.
Top Dividend Stocks To Buy [Or Sell] This Week
- Apple Inc. (NASDAQ: AAPL)
- 3M Inc. (NYSE: MMM)
- AbbVie Inc. (NYSE: ABBV)
- Microsoft Corporation (NASDAQ: MSFT)
First up, we have Apple, a multinational technology company that manufactures and sells its premium line of tech products. On top of that, it also offers a wide variety of services like its Apple TV+ video-on-demand streaming service and Apple Music. Furthermore, the company is one of the world’s most valuable brands and boasts a high level of brand loyalty among its users. AAPL stock currently trades at $142.94 as of Monday’s close. Its last dividend was declared in July at $0.22 per share.
The company has just recently announced its latest lineup of iPhone models. In fact, its iPhone 13 sales have just begun and millions have already placed orders for them. The company’s lineup this year also packs the latest features like a new A15 processor and 120 Hz display screen on its Pro model.
The company’s deals are also more aggressive this year and have partnered with carriers like T-Mobile (NASDAQ: TMUS) to offer huge incentives for users to trade in their old devices and sign up for a top-shelf cellular plan. Given this exciting piece of news surrounding the company, will you consider adding AAPL stock to your watchlist right now?
[Read More] 4 Semiconductor Stocks To Watch Right Now
The 3M Company
3M is a dividend company that has businesses in consumer goods, health care, worker safety, and industrials. Its products improve lives and help solve the world’s toughest challenges. The company’s portfolio of products includes abrasives and adhesives that are used for construction and are engineered to fit its customers’ needs.
Its array of high-performance materials are used to meet the demands of real-world manufacturing. MMM stock currently trades $180.53 at the end of Monday’s trading session. On August 13, 2021, the company declared a dividend on the company’s common stock of $1.48 per share for the third quarter.
Last week, the company announced that it’s Industrial Adhesives and Tapes Division is evolving its Bonding Process Centers in the U.S., Germany, and China to facilitate the growing trend towards automation in manufacturing. 3M will provide a starting point from which it will design and plan automated bonding solutions. The company will also have sessions to highlight how the company’s growing capabilities can be applied to increase more positive business outcomes for manufacturing and assembly businesses. For these reasons, will you consider MMM stock a buy today?
Following that, we have AbbVie, a company that develops and commercializes advanced therapies. It has over 48,000 employees globally that strive to help patients by providing them next-generation treatments and therapies. It focuses on several key therapeutic areas like immunology, oncology, neuroscience, and eye care among others. ABBV stock trades at $106.40 a share as of Monday’s close and has enjoyed gains of over 18% in the past year.
Today, the company announced that it has submitted an application to the FDA seeking approval for Risankizumab-rzaa, an interleukin-23 inhibitor for the treatment of patients 16 years and older with moderate to severe Crohn’s disease. The company submitted its safety and efficacy data from three Phase 3 studies to the FDA for this approval.
“While there have been advancements in care, many people with Crohn’s disease do not achieve lasting remission,” said Tom Hudson, senior vice president of research and development, chief scientific officer, AbbVie. “This submission is an important step forward in our commitment to providing an additional treatment option for those who struggle with this debilitating and often unpredictable disease.” With that being said, will you consider adding ABBV stock to your portfolio?
[Read More] What Stocks To Buy Today? 5 Tech Stocks To Watch
Another name to consider among dividend stocks in the stock market today would be the Microsoft Corporation. Sure, while Microsoft is not often first on most dividend stock lists, the company is not stingy when it comes to increasing its payouts. Namely, Microsoft has and continues to steadily grow its dividends for about 11 years. Thanks to its latest dividend hike, MSFT stock could be in focus among dividend investors now. As it stands, the company’s shares currently trade at $294.30 as of Monday’s closing bell after gaining 37% year-to-date.
In terms of its dividend, Microsoft announced that it would be boosting its dividend by a whopping 11% last week. While this adds up to a $0.06 per share quarterly payout, investors would be buying into the tech giants’ offerings as well. With pandemic conditions persisting worldwide, demand for Microsoft’s offerings could follow suit.
Even now, the company appears to be kicking into high gear across the board. Together with its dividend hike, Microsoft also plans to initiate a $60 billion share repurchase program, its largest to date. After considering all of this, would MSFT stock be worth investing in?default pandemic nasdaq equities stocks monetary policy fed federal reserve real estate treatment fda recovery germany china
Aurora Cannabis Reschedules Fourth Quarter and Full Fiscal Year 2021 Investor Conference Call and Related Year End Informational Filings to Monday, September 27, 2021
NASDAQ | TSX: ACB
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has rescheduled its conference call to discuss the results…
NASDAQ | TSX: ACB
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has rescheduled its conference call to discuss the results for its fourth quarter and full fiscal year 2021 to Monday, September 27, 2021 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time . The Company will report its financial results for the fourth quarter and full fiscal year 2021, and file its related annual disclosure documents, after the close of markets that same day.
New Conference Call Details
Monday, September 27, 2021
5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time
Miguel Martin , Chief Executive Officer, and Glen Ibbott , Chief Financial Officer, will host the conference call and question and answer period. Investors may submit questions in advance or during the conference call through the weblink listed above. This weblink has also been posted to the Company’s Investor Relations webpage at https://investor.auroramj.com/ under “News & Events”.
Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alberta , Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company’s brand portfolio includes Aurora, Aurora Drift, San Rafael ’71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora’s brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched. For more information, please visit our website at www.auroramj.com .
Aurora’s common shares trade on the NASDAQ and TSX under the symbol “ACB” and is a constituent of the S&P/TSX Composite Index.
Forward Looking Statements
This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking statements made in this news release include statements regarding: the timing for reporting of our financial results for the fourth quarter and full fiscal year 2021 and associated conference call. These forward-looking statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward looking statements are based on the opinions, estimates and assumptions of management in light of management’s experience and perception of historical trends, current conditions and expected developments at the date the statements are made, such as current and future market conditions, the ability to maintain SG&A costs in line with current expectations, the ability to achieve high margin revenues in the Canadian consumer market, the current and future regulatory environment and future approvals and permits. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including the risks associated with: entering the U.S. market, the ability to realize the anticipated benefits associated with the acquisition of Reliva, achievement of Aurora’s business transformation plan, general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual information form dated September 24, 2020 (the “AIF”) and filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at www.sedar.com and filed with and available on the SEC’s website at www.edgar.gov . The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.
View original content to download multimedia: https://www.prnewswire.com/news-releases/aurora-cannabis-reschedules-fourth-quarter-and-full-fiscal-year-2021-investor-conference-call-and-related-year-end-informational-filings-to-monday-september-27-2021-301380831.html
SOURCE Aurora Cannabis Inc.
News Provided by PR Newswire via QuoteMedia
Largest Uranium-producing Countries
Weekly Market Review: Stocks Take a Breather Ahead of Fed Meeting
COVID-19 Tests a Boon for Quest Diagnostics
Are Biotech Penny Stocks Worth Buying? Check These 3 Out
Dow Jones, the S&P 500, and Nasdaq weakened amid concerns around tax hikes and possible shifts in the U.S. Federal Reserve’s politics
Best Penny Stocks To Buy? 5 To Watch This Week With Biotech Catalysts
“What On Earth Is Going On In Commodities?”- Morgan Stanley Explains
Top 3 Penny Stocks For Your Weekly Watchlist in September
Top Penny Stocks to Buy Right Now? 3 to Check Out This Month
Here’s why Bitcoin might be safe from a global stock market crisis
Government23 hours ago
If Only We Could Find A Cure For Trump Derangement Syndrome
Stocks3 hours ago
Largest Uranium-producing Countries
Science10 hours ago
Are Biotech Penny Stocks Worth Buying? Check These 3 Out
Economics20 hours ago
Skyrocketing Energy Prices Could Cripple Europe’s Economy
Government17 hours ago
Steyn: A Hinge Moment Of History
Government16 hours ago
Markets Set To Drop As Fed “Taper” Approaches
Economics12 hours ago
Bzaar bags $4M to enable US retailers to source home, lifestyle products from India
Economics6 hours ago
Best Dividend Stocks In 2021? 4 To Watch This Week